Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01034852 · ClinicalTrials.gov registry record
Efficacy Study for Surgery After Previous Failed Catheter Ablation
A clinical trial of Atrial Fibrillation Ablation, sponsored by Cardiopulmonary Research Science and Technology Institute.
- Completed
- Registry status
- 45
- Enrollment target
- 2
- Study locations
NCT01034852: Completed study of Atrial Fibrillation Ablation, sponsored by Cardiopulmonary Research Science and Technology Institute.
NCT01034852 is a study of Atrial Fibrillation Ablation that has completed, run by Cardiopulmonary Research Science and Technology Institute. The registered enrollment target is 45 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01034852, a study of Atrial Fibrillation Ablation, has completed, sponsored by Cardiopulmonary Research Science and Technology Institute.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
Specific Aims: The primary objective of this registry is to determine the percentage of patients who are free from atrial fibrillation (AF) at 6 and 12 months following a surgical ablation procedure when the patient has a history of failing one or more previous catheter based ablations for AF. The first 3 months following surgical ablation will be a blanking period; any arrhythmia occurring during this time will not be used to determine success. Primary Objectives: 1. Determine the percent success of surgical ablation for AF at 6, and 12 months both on and off of antiarrhythmic drugs (AAD) following a failed catheter based ablation for AF 2. Record and evaluate all complications associated with the surgical procedure. Secondary Objectives: 1. Evaluate usage of anticoagulants at 6, and 12 months. 2. Determine the percentage of Pulmonary Veins (PV) that were electrically isolated by intra-operative, pre-surgical mapping
Conditions Studied
Interventions
- PROCEDURE Totally Thoracoscopic Maze
Study Locations (2)
Oregon
- Endovascular Research - Springfield
Texas
- Cardiopulmonary Research Science and Technology Institute - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-01 |
What the finished NCT01034852 record still lists
NCT01034852 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 1 condition, with Atrial Fibrillation Ablation appearing as the primary indexed condition, and to 1 intervention - of which Totally Thoracoscopic Maze is the first listed.
NCT01034852 reports a single indexed study location in Oregon, Texas.
Frequently Asked Questions
What is clinical trial NCT01034852 about?
NCT01034852 is a clinical study titled "Efficacy Study for Surgery After Previous Failed Catheter Ablation". Specific Aims: The primary objective of this registry is to determine the percentage of patients who are free from atrial fibrillation (AF) at 6 and 12 months following a surgical ablation procedure when the patient has a history of failing one or more previous catheter based ablations for AF. The f...
What is the current status of trial NCT01034852?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2009-05. Estimated completion is 2011-01.
What conditions does trial NCT01034852 study?
This clinical trial studies the following conditions: Atrial Fibrillation Ablation.
What interventions are being tested in trial NCT01034852?
The interventions under investigation include: Totally Thoracoscopic Maze (PROCEDURE).
Who is sponsoring clinical trial NCT01034852?
This trial is sponsored by Cardiopulmonary Research Science and Technology Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01034852 being conducted?
This trial has 2 study locations across Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia